Abdullah Esmail, Saifudeen Abdelrahim, Yazan Hamadneh, Nour Maher Mustafa, Ebtesam Al-Najjar, Maen Abdelrahim. "Durvalumab or pembrolizumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy for advanced cholangiocarcinoma: A meta-analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4160